Multiple exon skipping strategies to by-pass dystrophin mutations

Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon...

Full description

Bibliographic Details
Main Authors: Adkin, Carl F., Meloni, Penelope L., Fletcher, Susan, Adams, Abbie M., Muntoni, Francesco, Wong, Brenda, Wilton, Steve D.
Format: Online
Language:English
Published: Pergamon Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488593/
id pubmed-3488593
recordtype oai_dc
spelling pubmed-34885932013-04-01 Multiple exon skipping strategies to by-pass dystrophin mutations Adkin, Carl F. Meloni, Penelope L. Fletcher, Susan Adams, Abbie M. Muntoni, Francesco Wong, Brenda Wilton, Steve D. Article Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon skipping strategies exist to restore dystrophin expression. However, for some small intra-exonic mutations, a third strategy, not applicable to whole exon deletions, may be possible. The removal of only one frame-shifting exon flanking the mutation-carrying exon may restore the reading frame and allow synthesis of a functional dystrophin isoform, providing that no premature termination codons are encountered. For these mutations, the removal of only one exon offers a simpler, cheaper and more feasible alternative approach to the dual exon skipping that would otherwise be considered. We present strategies to by-pass intra-exonic dystrophin mutations that clearly demonstrate the importance of tailoring exon skipping strategies to specific patient mutations. Pergamon Press 2012-04 /pmc/articles/PMC3488593/ /pubmed/22182525 http://dx.doi.org/10.1016/j.nmd.2011.10.007 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Adkin, Carl F.
Meloni, Penelope L.
Fletcher, Susan
Adams, Abbie M.
Muntoni, Francesco
Wong, Brenda
Wilton, Steve D.
spellingShingle Adkin, Carl F.
Meloni, Penelope L.
Fletcher, Susan
Adams, Abbie M.
Muntoni, Francesco
Wong, Brenda
Wilton, Steve D.
Multiple exon skipping strategies to by-pass dystrophin mutations
author_facet Adkin, Carl F.
Meloni, Penelope L.
Fletcher, Susan
Adams, Abbie M.
Muntoni, Francesco
Wong, Brenda
Wilton, Steve D.
author_sort Adkin, Carl F.
title Multiple exon skipping strategies to by-pass dystrophin mutations
title_short Multiple exon skipping strategies to by-pass dystrophin mutations
title_full Multiple exon skipping strategies to by-pass dystrophin mutations
title_fullStr Multiple exon skipping strategies to by-pass dystrophin mutations
title_full_unstemmed Multiple exon skipping strategies to by-pass dystrophin mutations
title_sort multiple exon skipping strategies to by-pass dystrophin mutations
description Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore the reading frame and in some cases, multiple exon skipping strategies exist to restore dystrophin expression. However, for some small intra-exonic mutations, a third strategy, not applicable to whole exon deletions, may be possible. The removal of only one frame-shifting exon flanking the mutation-carrying exon may restore the reading frame and allow synthesis of a functional dystrophin isoform, providing that no premature termination codons are encountered. For these mutations, the removal of only one exon offers a simpler, cheaper and more feasible alternative approach to the dual exon skipping that would otherwise be considered. We present strategies to by-pass intra-exonic dystrophin mutations that clearly demonstrate the importance of tailoring exon skipping strategies to specific patient mutations.
publisher Pergamon Press
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488593/
_version_ 1611921250644393984